标题
Aminopeptidase N (CD13) as a target for cancer chemotherapy
作者
关键词
-
出版物
CANCER SCIENCE
Volume 102, Issue 3, Pages 501-508
出版商
Wiley
发表日期
2010-12-09
DOI
10.1111/j.1349-7006.2010.01826.x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The alkylating prodrug J1 can be activated by aminopeptidase N, leading to a possible target directed release of melphalan
- (2010) Malin Wickström et al. BIOCHEMICAL PHARMACOLOGY
- LYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin
- (2010) Jian-Jun Gao et al. INVESTIGATIONAL NEW DRUGS
- Phase II Study of Asparagine-Glycine-Arginine–Human Tumor Necrosis Factor α, a Selective Vascular Targeting Agent, in Previously Treated Patients With Malignant Pleural Mesothelioma
- (2010) Vanesa Gregorc et al. JOURNAL OF CLINICAL ONCOLOGY
- Nanoparticles Targeted With NGR Motif Deliver c-myc siRNA and Doxorubicin for Anticancer Therapy
- (2010) Yunching Chen et al. MOLECULAR THERAPY
- Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experience
- (2009) R. Bieker et al. BLOOD
- Phase Ib study of NGR–hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours
- (2009) V Gregorc et al. BRITISH JOURNAL OF CANCER
- A First-in-Man Phase I and Pharmacokinetic Study on CHR-2797 (Tosedostat), an Inhibitor of M1 Aminopeptidases, in Patients with Advanced Solid Tumors
- (2009) A. H.M. Reid et al. CLINICAL CANCER RESEARCH
- Defining the optimal biological dose of NGR-hTNF, a selective vascular targeting agent, in advanced solid tumours
- (2009) Vanesa Gregorc et al. EUROPEAN JOURNAL OF CANCER
- NGR-modified micelles enhance their interaction with CD13-overexpressing tumor and endothelial cells
- (2009) Xun Wang et al. JOURNAL OF CONTROLLED RELEASE
- Aminopeptidase N (APN)/CD13 inhibitor, Ubenimex, enhances radiation sensitivity in human cervical cancer
- (2008) Hirohisa Tsukamoto et al. BMC CANCER
- CHR-2797: An Antiproliferative Aminopeptidase Inhibitor that Leads to Amino Acid Deprivation in Human Leukemic Cells
- (2008) D. Krige et al. CANCER RESEARCH
- Enhanced Antitumor Efficacy of Clinical-Grade Vasculature-Targeted Liposomal Doxorubicin
- (2008) F. Pastorino et al. CLINICAL CANCER RESEARCH
- Aminopeptidase N (APN/CD13) as a Target for Anti-Cancer Agent Design
- (2008) Xiaopan Zhang et al. CURRENT MEDICINAL CHEMISTRY
- In vivo optical imaging of CD13/APN-expression in tumor xenografts
- (2008) Angelika von Wallbrunn et al. JOURNAL OF BIOMEDICAL OPTICS
- Vasculature-targeted tumor necrosis factor-alpha increases the therapeutic index of doxorubicin against prostate cancer
- (2008) Maria T.S. Bertilaccio et al. PROSTATE
- The moonlighting enzyme CD13: old and new functions to target
- (2008) Paola Mina-Osorio TRENDS IN MOLECULAR MEDICINE
- Conjugated Platinum(IV)−Peptide Complexes for Targeting Angiogenic Tumor Vasculature
- (2007) Sumitra Mukhopadhyay et al. BIOCONJUGATE CHEMISTRY
- Aminopeptidase N (APN)/CD13-dependent CXCR4 downregulation is associated with diminished cell migration, proliferation and invasion
- (2007) Jens Wulfaenger et al. MOLECULAR MEMBRANE BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now